Review article · 2025 · Open access

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases

Mingwei Jiang, Jinrong Zhao, Jinguo Yuan, Zixian Yu, Jie Liu, Zhanxin Zhu, Xiaoxuan Ning, Shiren Sun

Human Vaccines & Immunotherapeutics, 21(1), 2538350 · Published 1 August 2025 · DOI 10.1080/21645515.2025.2538350

Open PDFView at the publisherCite this paper

In brief

“Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases” is a 2025 review article by Mingwei Jiang and 7 co-authors, published in Human Vaccines & Immunotherapeutics. OpenAlex counts 9 citations as of 19 November 2026, which puts it in the top 7% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Human Vaccines & Immunotherapeutics.

Citations
9
Most cited in
2026 (7)
Field-weighted impact
0.90
References
230
Authors
8

Abstract

Emerging as a paradigm-shifting therapeutic strategy initially developed for hematological malignancies, chimeric antigen receptor (CAR)-based cell therapy has recently proved transformative potential in autoimmune disease management. CAR T cell therapy has achieved long-term remission without drugs in a variety of autoimmune diseases. Chimeric autoantigen receptor T cell therapy targeting specific B cell receptors has transitioned from preclinical research to clinical trials. CAR natural killer cell therapy has shown promising efficacy and safety in early-stage clinical trials. The evolution of CAR regulatory T cell and mesenchymal stem cell therapy has also achieved initial results. These achievements have greatly inspired researchers, and more research is being actively carried out in the field of autoimmune diseases, aiming to develop more efficient, safe and convenient cell products. This article will detail the effectiveness and applicability of CAR-based immunotherapy in the management of autoimmune diseases, and explore its limitations and future trends.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jiang, M., Zhao, J., Yuan, J., Yu, Z., Liu, J., Zhu, Z., Ning, X., & Sun, S. (2025). Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. Human Vaccines & Immunotherapeutics, 21(1), 2538350. https://doi.org/10.1080/21645515.2025.2538350

MLA 9

Jiang, Mingwei, et al. “Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases.” Human Vaccines & Immunotherapeutics, vol. 21, no. 1, 2025, p. 2538350. https://doi.org/10.1080/21645515.2025.2538350.

Chicago

Jiang, Mingwei, Jinrong Zhao, Jinguo Yuan, Zixian Yu, Jie Liu, Zhanxin Zhu, Xiaoxuan Ning, and Shiren Sun. 2025. “Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases.” Human Vaccines & Immunotherapeutics 21 (1): 2538350. https://doi.org/10.1080/21645515.2025.2538350.

Harvard

Jiang, M. et al. (2025) ‘Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases’, Human Vaccines & Immunotherapeutics, 21(1), p. 2538350. doi:10.1080/21645515.2025.2538350.

IEEE

M. Jiang et al., “Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases,” Human Vaccines & Immunotherapeutics, vol. 21, no. 1, p. 2538350, 2025, doi: 10.1080/21645515.2025.2538350.

BibTeX

@article{jiang2025research,
  title     = {{Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases}},
  author    = {Jiang, Mingwei and Zhao, Jinrong and Yuan, Jinguo and Yu, Zixian and Liu, Jie and Zhu, Zhanxin and Ning, Xiaoxuan and Sun, Shiren},
  journal   = {Human Vaccines \& Immunotherapeutics},
  year      = {2025},
  volume    = {21},
  number    = {1},
  pages     = {2538350},
  doi       = {10.1080/21645515.2025.2538350},
  url       = {https://doi.org/10.1080/21645515.2025.2538350}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • chimeric antigen receptor
  • CAR T-cell therapy
  • autoimmune disease
  • CAR-NK cells
  • autoantigens
  • cell therapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Jiang, M., Zhao, J., Yuan, J., Yu, Z., Liu, J., Zhu, Z., Ning, X., & Sun, S. (2025). Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. Human Vaccines & Immunotherapeutics, 21(1), 2538350. https://doi.org/10.1080/21645515.2025.2538350

How many times has this paper been cited?

9 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Human Vaccines & Immunotherapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Mingwei Jiang, Jinrong Zhao, Jinguo Yuan, Zixian Yu, Jie Liu, Zhanxin Zhu, Xiaoxuan Ning, Shiren Sun.

What is the DOI of this paper?

10.1080/21645515.2025.2538350, permanently at https://doi.org/10.1080/21645515.2025.2538350. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.